Lupron Depot-PED

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:approves gptkb:2009
gptkb:FDA
gptkbp:availability commercially available
gptkbp:class hormonal therapy
gptkbp:clinical_trial Phase 3
effective in reducing premature puberty
well-tolerated in children
gptkbp:clinical_use pediatric endocrinology
gptkbp:competitors competes with other Gn RH agonists
gptkbp:contraindication pregnancy
breastfeeding
hypersensitivity to leuprolide
gptkbp:dosage_form depot injection
gptkbp:drug_interactions anticoagulants
antidiabetic medications
other Gn RH analogs
gptkbp:duration monthly administration
gptkbp:feedback generally positive
some report side effects
gptkbp:financial_support available through manufacturer
gptkbp:formulation sustained-release
injectable suspension
https://www.w3.org/2000/01/rdf-schema#label Lupron Depot-PED
gptkbp:indication delaying puberty
gptkbp:ingredients gptkb:leuprolide_acetate
gptkbp:is_monitored_by growth rate
bone density
hormone levels
gptkbp:manufacturer gptkb:Abb_Vie
gptkbp:marketed_as Lupron Depot for Pediatric Patients
gptkbp:mechanism_of_action Gn RH agonist
gptkbp:packaging single-dose vial
gptkbp:patient_education potential side effects
injection technique
importance of follow-up visits
gptkbp:patient_population gptkb:children
gptkbp:pharmacokinetics long half-life
suppresses gonadotropin release
gptkbp:price varies by insurance
gptkbp:provides_guidance_on recommended for CPP
gptkbp:regulatory_compliance prescription only
gptkbp:related_products gptkb:Lupron
gptkb:Eligard
Viadur
gptkbp:research ongoing studies on long-term effects
gptkbp:route_of_administration intramuscular injection
gptkbp:side_effect gptkb:anemia
gptkb:depression
fatigue
nausea
weight gain
headaches
injection site reactions
osteoporosis
mood changes
hot flashes
gptkbp:storage store at room temperature
gptkbp:type_of_care important for efficacy
gptkbp:used_for treatment of central precocious puberty
gptkbp:bfsParent gptkb:Lupron
gptkbp:bfsLayer 6